Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Vassiliki Tzanetakou"'
Autor:
Theodora Kanni, Vassiliki Tzanetakou, Athina Savva, Brigit Kersten, Aikaterini Pistiki, Frank L van de Veerdonk, Mihai G Netea, Jos W van der Meer, Evangelos J Giamarellos-Bourboulis
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0130522 (2015)
Favorable treatment outcomes with TNF blockade led us to explore cytokine responses in hidradenitis suppurativa (HS).Blood monocytes of 120 patients and 24 healthy volunteers were subtyped by flow cytometry. Isolated blood mononuclear cells (PBMCs) w
Externí odkaz:
https://doaj.org/article/c089d7dc5cf14f40854511308559a40b
Autor:
Dimitra Stergianou, Styliani Micha, Vassiliki Tzanetakou, Theodora Kanni, Theologia Gkavogianni, Alexandros Katoulis, Evangelos J. Giamarellos-Bourboulis
Publikováno v:
Journal of Investigative Dermatology.
Autor:
Christopher Schofield, Vassiliki Tzanetakou, Andreas S Lappas, Lori Edwards Suarez, Nikos G. Christodoulou, Sally C. Morton
Publikováno v:
Australasian Psychiatry. 30:44-48
Objective: To establish whether there is a significant change in suicidality risk following psychiatric assessment for commencement of isotretinoin and identify factors that underpin any potential risk change. Method: Retrospective cohort study. Suic
Autor:
Theodora Kanni, Dimitra Stergianou, Pantelis G. Bagos, Maria D. Argyropoulou, Evangelos J. Giamarellos-Bourboulis, Vassiliki Tzanetakou
Publikováno v:
Dermatology. 237:372-377
Background: Several patients with hidradenitis suppurativa (HS) present flare-ups during treatment with adalimumab (ADA), the cause of which is not clear. ADA is the only FDA-approved biologic for the therapy of moderate-to-severe HS. A previous stud
Publikováno v:
American Journal of Clinical Dermatology. 20:515-526
Vitiligo is a common acquired depigmenting skin disease characterized by a progressive loss of functional melanocytes. It may appear from the first years of life to late adulthood. Childhood vitiligo (CV), defined as vitiligo that begins before the a
Autor:
Christina Antoniou, Alexander J. Stratigos, Vasiliki Chasapi, Vassiliki Tzanetakou, Angeliki Befon, Antonios Panagiotopoulos
Publikováno v:
International Journal of Dermatology
Background Imiquimod 3.75% is a field‐directed treatment for actinic keratosis that can detect and treat clinical and subclinical lesions across an entire sun‐exposed field. The detection of subclinical lesions is evidenced by an increase in lesi
Autor:
Dimitra, Stergianou, Vassiliki, Tzanetakou, Maria, Argyropoulou, Theodora, Kanni, Pantelis G, Bagos, Evangelos J, Giamarellos-Bourboulis
Publikováno v:
Dermatology (Basel, Switzerland). 237(3)
Several patients with hidradenitis suppurativa (HS) present flare-ups during treatment with adalimumab (ADA), the cause of which is not clear. ADA is the only FDA-approved biologic for the therapy of moderate-to-severe HS. A previous study of our gro
Publikováno v:
Expert opinion on drug safety. 19(4)
Introduction: Hidradenitis suppurativa (HS) is a chronic debilitating inflammatory skin disorder that affects regions rich in apocrine glands. Although the etiology of HS is not clear, inflammatory...
Autor:
Andreas Katsambas, E. Koukkou, Chrisa Zisimou, Eftychia Platsidaki, Ch. Antoniou, Clio Dessinioti, Vassiliki Tzanetakou
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 32:e279-e282
Publikováno v:
Hyperpigmentation ISBN: 9781315162478
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbf730cfeb4b282aa22fa828f44c9f65
https://doi.org/10.1201/9781315162478-6
https://doi.org/10.1201/9781315162478-6